Safety, Blood Levels and Effects of AUT00201 in Patients With MEAK
Clinical trial NCT05873062 · COMPLETED
Trial details
- NCT number
- NCT05873062
- Sponsor
- Autifony Therapeutics Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-12
- Primary completion
- 2024-05-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.